Consolidated Statements of Changes In Stockholders' Equity - USD ($)	Series H Preferred Stock [Member]	Series H-3 Preferred Stock [Member] Common Stock [Member]	Series H-3 Preferred Stock [Member]	Series H-6 Preferred Stock [Member]	Series Seed Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated (Deficit) [Member]	Total
Balance at Dec. 31, 2018					$ 4,270,507	$ 279	$ 1,131,551	$ (5,293,951)	$ 108,386
Balance, shares at Dec. 31, 2018					3,882,791	2,793,591
Preferred Stock issued for Cash					$ 4,754,738				4,754,738
Preferred Stock issued for Cash, shares					3,478,194
Sale of common stock, net of fees						$ 116	4,118		4,234
Sale of common stock, net of fees, shares						1,154,487
Stock based compensation							3,372,726		3,372,726
Discount on Debt							493,552		493,552
Net Loss								(8,664,693)	(8,664,693)
Balance at Dec. 31, 2019					$ 9,025,245	$ 395	5,001,947	(13,958,644)	68,943
Balance, shares at Dec. 31, 2019					7,360,985	3,948,078
Conversion of AYRO Preferred Stock to common stock					$ (9,025,245)	$ 201	9,025,044
Conversion of AYRO Preferred Stock to common stock, shares		955			(7,360,985)	2,007,193
Issuance of Series Preferred Stock in connection with the 2020 Merger
Issuance of Series Preferred Stock in connection with the 2020 Merger, shares	8		2,189	7,883
Conversion of Series H-6 Preferred Stock						$ 23	(23)
Conversion of Series H-6 Preferred Stock, shares				(7,833)		225,590
Issuance of Common Stock in connection with the 2020 Merger, net of fees						$ 495	4,451,235		4,451,730
Issuance of Common Stock in connection with the 2020 Merger, net of fees, shares						4,948,377
Exchange of debt for common stock in connection with the 2020 Merger						$ 103	999,897		1,000,000
Exchange of debt for common stock in connection with the 2020 Merger, shares						1,030,585
Issuance of common stock in connection with debt offering						$ 56	461,957		462,013
Issuance of common stock in connection with debt offering, shares						553,330
Sale of common stock, net of fees						$ 928	38,409,253		38,410,181
Sale of common stock, net of fees, shares						9,278,059
Conversion of Series H-3 Preferred Stock, shares						795
Exercise of warrants, net of fees						$ 507	3,926,311		3,926,818
Exercise of warrants, net of fees, shares						5,074,645
Exercise of stock options							16,669		16,669
Exercise of stock options, shares						6,817
Stock based compensation							1,736,791		1,736,791
Vested restricted stock						$ 1	47,916		47,917
Vested restricted stock, shares						15,115
Deemed divided on modification of H-5 warrants							432,727	(432,727)
Net Loss								(10,763,446)	(10,763,446)
Balance at Dec. 31, 2020						$ 2,709	$ 64,509,724	$ (25,154,817)	$ 39,357,616
Balance, shares at Dec. 31, 2020	8		1,234	50		27,088,584